StonvexLoading…
StonvexStonvexStonvexCore line items from OBK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $537.96M | $564.59M | $523.39M | $326.60M |
Operating Income | $95.64M | $97.26M | $105.92M | $107.44M |
Net Income | $75.20M | $76.49M | $83.80M | $87.72M |
EPS (Diluted) | $2.40 | $2.45 | $2.71 | $3.28 |
Total Assets | $9.72B | $9.68B | $9.72B | $9.69B |
Total Liabilities | $8.48B | $8.53B | $8.66B | $8.74B |
Cash & Equivalents | $424.22M | $470.25M | $280.44M | $358.97M |
Free Cash Flow OCF − CapEx | $151.05M | $86.43M | $103.09M | $137.18M |
Shares Outstanding | 31.33M | 31.20M | 30.93M | 26.76M |